{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:38:18Z","timestamp":1789900698784,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Insulin like growth factor binding proteins modulate the mitogenic and pro survival effects of IGF. Elevated expression of IGFBP2 is associated with progression of tumors that include prostate, ovarian, glioma among others. Though implicated in the progression of breast cancer, the molecular mechanisms involved in IGFBP2 actions are not well defined. This study investigates the molecular targets and biological pathways targeted by IGFBP2 in breast cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Transcriptome analysis of breast tumor cells (BT474) with stable knockdown of IGFBP2 and breast tumors having differential expression of IGFBP2 by immunohistochemistry was performed using microarray. Differential gene expression was established using R-Bioconductor package. For validation, gene expression was determined by qPCR. Inhibitors of IGF1R and integrin pathway were utilized to study the mechanism of regulation of \u03b2-catenin. Immunohistochemical and immunocytochemical staining was performed on breast tumors and experimental cells, respectively for \u03b2-catenin and IGFBP2 expression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Knockdown of IGFBP2 resulted in differential expression of 2067 up regulated and 2002 down regulated genes in breast cancer cells. Down regulated genes principally belong to cell cycle, DNA replication, repair, p53 signaling, oxidative phosphorylation, Wnt signaling. Whole genome expression analysis of breast tumors with or without IGFBP2 expression indicated changes in genes belonging to Focal adhesion, Map kinase and Wnt signaling pathways. Interestingly, IGFBP2 knockdown clones showed reduced expression of \u03b2- catenin compared to control cells which was restored upon IGFBP2 re-expression. The regulation of \u03b2-catenin by IGFBP2 was found to be IGF1R and integrin pathway dependent. Furthermore, IGFBP2 and \u03b2-catenin are co-ordinately overexpressed in breast tumors and correlate with lymph node metastasis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study highlights regulation of \u03b2-catenin by IGFBP2 in breast cancer cells and most importantly, combined expression of IGFBP2 and \u03b2-catenin is associated with lymph node metastasis of breast tumors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1476-4598-12-63","type":"journal-article","created":{"date-parts":[[2013,6,16]],"date-time":"2013-06-16T08:13:59Z","timestamp":1371370439000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Regulation of protumorigenic pathways by Insulin like growth factor binding protein2 and its association along with \u03b2-catenin in breast cancer lymph node metastasis"],"prefix":"10.1186","volume":"12","author":[{"given":"Priyanka","family":"Sehgal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varuvar Rajesh","family":"Praveen Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Animesh","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manavalan","family":"Vijaya Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetashree","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paturu","family":"Kondaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,16]]},"reference":[{"key":"1134_CR1","first-page":"8601","volume":"61","author":"A Hoeflich","year":"2001","unstructured":"Hoeflich A, Reisinger R, Lahm H, Kiess W, Blum WF, Kolb HJ, Weber MM, Wolf E: Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter?. Cancer Res. 2001, 61: 8601-8610.","journal-title":"Cancer Res"},{"key":"1134_CR2","first-page":"4228","volume":"59","author":"GN Fuller","year":"1999","unstructured":"Fuller GN, Rhee CH, Hess KR, Caskey LS, Wang R, Bruner JM, Yung WK, Zhang W: Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. Cancer Res. 1999, 59: 4228-4232.","journal-title":"Cancer Res"},{"key":"1134_CR3","first-page":"4315","volume":"63","author":"H Wang","year":"2003","unstructured":"Wang H, Shen W, Huang H, Hu L, Ramdas L, Zhou YH, Liao WS, Fuller GN, Zhang W: Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res. 2003, 63: 4315-4321.","journal-title":"Cancer Res"},{"key":"1134_CR4","first-page":"6617","volume":"60","author":"SL Sallinen","year":"2000","unstructured":"Sallinen SL, Sallinen PK, Haapasalo HK, Helin HJ, Helen PT, Schraml P, Kallioniemi OP, Kononen J: Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res. 2000, 60: 6617-6622.","journal-title":"Cancer Res"},{"key":"1134_CR5","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/modpathol.3800637","volume":"19","author":"H Wang","year":"2006","unstructured":"Wang H, Rosen DG, Fuller GN, Zhang W, Liu J: Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types. Mod Pathol. 2006, 19: 1149-1156. 10.1038\/modpathol.3800637","journal-title":"Mod Pathol"},{"key":"1134_CR6","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1210\/jc.82.7.2308","volume":"82","author":"A Flyvbjerg","year":"1997","unstructured":"Flyvbjerg A, Mogensen O, Mogensen B, Nielsen OS: Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor. J Clin Endocrinol Metab. 1997, 82: 2308-2313. 10.1210\/jc.82.7.2308","journal-title":"J Clin Endocrinol Metab"},{"key":"1134_CR7","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1002\/pmic.200500702","volume":"6","author":"R Chen","year":"2006","unstructured":"Chen R, Pan S, Yi EC, Donohoe S, Bronner MP, Potter JD, Goodlett DR, Aebersold R, Brentnall TA: Quantitative proteomic profiling of pancreatic cancer juice. Proteomics. 2006, 6: 3871-3879. 10.1002\/pmic.200500702","journal-title":"Proteomics"},{"key":"1134_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s10620-006-9358-z","volume":"52","author":"L Zhang","year":"2007","unstructured":"Zhang L, Huang W, Chen J, Zhou X, Lu Z, Zhou H: Expression of IGFBP2 in gastric carcinoma and relationship with clinicopathologic parameters and cell proliferation. Dig Dis Sci. 2007, 52: 248-253. 10.1007\/s10620-006-9358-z","journal-title":"Dig Dis Sci"},{"key":"1134_CR9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1210\/jc.77.1.229","volume":"77","author":"H Kanety","year":"1993","unstructured":"Kanety H, Madjar Y, Dagan Y, Levi J, Papa MZ, Pariente C, Goldwasser B, Karasik A: Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J Clin Endocrinol Metab. 1993, 77: 229-233. 10.1210\/jc.77.1.229","journal-title":"J Clin Endocrinol Metab"},{"key":"1134_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S1096-6374(98)80300-6","volume":"8","author":"L Mishra","year":"1998","unstructured":"Mishra L, Bass B, Ooi BS, Sidawy A, Korman L: Role of insulin-like growth factor-I (IGF-I) receptor, IGF-I, and IGF binding protein-2 in human colorectal cancers. Growth Horm IGF Res. 1998, 8: 473-479. 10.1016\/S1096-6374(98)80300-6","journal-title":"Growth Horm IGF Res"},{"key":"1134_CR11","doi-asserted-by":"publisher","first-page":"6944","DOI":"10.1158\/1078-0432.CCR-08-0408","volume":"14","author":"AI So","year":"2008","unstructured":"So AI, Levitt RJ, Eigl B, Fazli L, Muramaki M, Leung S, Cheang MC, Nielsen TO, Gleave M, Pollak M: Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancer. Clin Cancer Res. 2008, 14: 6944-6954. 10.1158\/1078-0432.CCR-08-0408","journal-title":"Clin Cancer Res"},{"key":"1134_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/jcp.2004.020834","volume":"58","author":"LT Busund","year":"2005","unstructured":"Busund LT, Richardsen E, Busund R, Ukkonen T, Bjornsen T, Busch C, Stalsberg H: Significant expression of IGFBP2 in breast cancer compared with benign lesions. J Clin Pathol. 2005, 58: 361-366. 10.1136\/jcp.2004.020834","journal-title":"J Clin Pathol"},{"key":"1134_CR13","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/bjc.1998.525","volume":"78","author":"H Wex","year":"1998","unstructured":"Wex H, Vorwerk P, Mohnike K, Bretschneider D, Kluba U, Aumann V, Blum WF, Mittler U: Elevated serum levels of IGFBP-2 found in children suffering from acute leukaemia is accompanied by the occurrence of IGFBP-2 mRNA in the tumour clone. Br J Cancer. 1998, 78: 515-520. 10.1038\/bjc.1998.525","journal-title":"Br J Cancer"},{"key":"1134_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1089\/thy.1995.5.67","volume":"5","author":"BF van der Laan","year":"1995","unstructured":"van der Laan BF, Freeman JL, Asa SL: Expression of growth factors and growth factor receptors in normal and tumorous human thyroid tissues. Thyroid. 1995, 5: 67-73. 10.1089\/thy.1995.5.67","journal-title":"Thyroid"},{"key":"1134_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/nen.0b013e31804567d7","volume":"66","author":"KL McDonald","year":"2007","unstructured":"McDonald KL, O\u2019Sullivan MG, Parkinson JF, Shaw JM, Payne CA, Brewer JM, Young L, Reader DJ, Wheeler HT, Cook RJ: IQGAP1 and IGFBP2: valuable biomarkers for determining prognosis in glioma patients. J Neuropathol Exp Neurol. 2007, 66: 405-417. 10.1097\/nen.0b013e31804567d7","journal-title":"J Neuropathol Exp Neurol"},{"key":"1134_CR16","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1215\/15228517-2008-114","volume":"11","author":"Y Lin","year":"2009","unstructured":"Lin Y, Jiang T, Zhou K, Xu L, Chen B, Li G, Qiu X, Zhang W, Song SW: Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas. Neuro Oncol. 2009, 11: 468-476. 10.1215\/15228517-2008-114","journal-title":"Neuro Oncol"},{"key":"1134_CR17","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1210\/jc.2009-2668","volume":"95","author":"JM Liou","year":"2010","unstructured":"Liou JM, Shun CT, Liang JT, Chiu HM, Chen MJ, Chen CC, Wang HP, Wu MS, Lin JT: Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer. J Clin Endocrinol Metab. 2010, 95: 1717-1725. 10.1210\/jc.2009-2668","journal-title":"J Clin Endocrinol Metab"},{"key":"1134_CR18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.eururo.2004.12.015","volume":"47","author":"BA Inman","year":"2005","unstructured":"Inman BA, Harel F, Audet JF, Meyer F, Douville P, Fradet Y, Lacombe L: Insulin-like growth factor binding protein 2: an androgen-dependent predictor of prostate cancer survival. Eur Urol. 2005, 47: 695-702. 10.1016\/j.eururo.2004.12.015","journal-title":"Eur Urol"},{"key":"1134_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/ijc.11015","volume":"105","author":"MG Moore","year":"2003","unstructured":"Moore MG, Wetterau LA, Francis MJ, Peehl DM, Cohen P: Novel stimulatory role for insulin-like growth factor binding protein-2 in prostate cancer cells. Int J Cancer. 2003, 105: 14-19. 10.1002\/ijc.11015","journal-title":"Int J Cancer"},{"key":"1134_CR20","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/bjc.2011.127","volume":"104","author":"CC Uzoh","year":"2011","unstructured":"Uzoh CC, Holly JM, Biernacka KM, Persad RA, Bahl A, Gillatt D, Perks CM: Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel. Br J Cancer. 2011, 104: 1587-1593. 10.1038\/bjc.2011.127","journal-title":"Br J Cancer"},{"key":"1134_CR21","first-page":"E922","volume":"271","author":"A Hoeflich","year":"1996","unstructured":"Hoeflich A, Yang Y, Huber S, Rascher W, Koepf G, Blum WF, Heinz-Erian P, Kolb HJ, Kiess W: Expression of IGFBP-2, -3, and \u22124 mRNA during differentiation of Caco-2 colon epithelial cells. Am J Physiol. 1996, 271: E922-E931.","journal-title":"Am J Physiol"},{"key":"1134_CR22","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1210\/jc.81.10.3709","volume":"81","author":"SR Plymate","year":"1996","unstructured":"Plymate SR, Tennant M, Birnbaum RS, Thrasher JB, Chatta G, Ware JL: The effect on the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by simian virus-40 T antigen. J Clin Endocrinol Metab. 1996, 81: 3709-3716. 10.1210\/jc.81.10.3709","journal-title":"J Clin Endocrinol Metab"},{"key":"1134_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1210\/en.135.1.223","volume":"135","author":"RS Birnbaum","year":"1994","unstructured":"Birnbaum RS, Wiren KM: Changes in insulin-like growth factor-binding protein expression and secretion during the proliferation, differentiation, and mineralization of primary cultures of rat osteoblasts. Endocrinology. 1994, 135: 223-230. 10.1210\/en.135.1.223","journal-title":"Endocrinology"},{"key":"1134_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4161\/cbt.5.2.2333","volume":"5","author":"S Chakrabarty","year":"2006","unstructured":"Chakrabarty S, Kondratick L: Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogen-activated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells. Cancer Biol Ther. 2006, 5: 189-197. 10.4161\/cbt.5.2.2333","journal-title":"Cancer Biol Ther"},{"key":"1134_CR25","doi-asserted-by":"publisher","first-page":"18634","DOI":"10.1074\/jbc.M609567200","volume":"282","author":"T Fukushima","year":"2007","unstructured":"Fukushima T, Tezuka T, Shimomura T, Nakano S, Kataoka H: Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24. J Biol Chem. 2007, 282: 18634-18644. 10.1074\/jbc.M609567200","journal-title":"J Biol Chem"},{"key":"1134_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1476-4598-4-7","volume":"4","author":"EJ Lee","year":"2005","unstructured":"Lee EJ, Mircean C, Shmulevich I, Wang H, Liu J, Niemisto A, Kavanagh JJ, Lee JH, Zhang W: Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion. Mol Cancer. 2005, 4: 7- 10.1186\/1476-4598-4-7","journal-title":"Mol Cancer"},{"key":"1134_CR27","first-page":"341","volume":"13","author":"H Miyake","year":"2005","unstructured":"Miyake H, Hara I, Yamanaka K, Muramaki M, Gleave M, Eto H: Introduction of insulin-like growth factor binding protein-2 gene into human bladder cancer cells enhances their metastatic potential. Oncol Rep. 2005, 13: 341-345.","journal-title":"Oncol Rep"},{"key":"1134_CR28","doi-asserted-by":"publisher","first-page":"11736","DOI":"10.1073\/pnas.0703145104","volume":"104","author":"SM Dunlap","year":"2007","unstructured":"Dunlap SM, Celestino J, Wang H, Jiang R, Holland EC, Fuller GN, Zhang W: Insulin-like growth factor binding protein 2 promotes glioma development and progression. Proc Natl Acad Sci USA. 2007, 104: 11736-11741. 10.1073\/pnas.0703145104","journal-title":"Proc Natl Acad Sci USA"},{"key":"1134_CR29","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1073\/pnas.1120375109","volume":"109","author":"KM Holmes","year":"2012","unstructured":"Holmes KM, Annala M, Chua CY, Dunlap SM, Liu Y, Hugen N, Moore LM, Cogdell D, Hu L, Nykter M: Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-kappaB network. Proc Natl Acad Sci USA. 2012, 109: 3475-3480. 10.1073\/pnas.1120375109","journal-title":"Proc Natl Acad Sci USA"},{"key":"1134_CR30","doi-asserted-by":"publisher","first-page":"14085","DOI":"10.1074\/jbc.M513686200","volume":"281","author":"GK Wang","year":"2006","unstructured":"Wang GK, Hu L, Fuller GN, Zhang W: An interaction between insulin-like growth factor-binding protein 2 (IGFBP2) and integrin alpha5 is essential for IGFBP2-induced cell mobility. J Biol Chem. 2006, 281: 14085-14091. 10.1074\/jbc.M513686200","journal-title":"J Biol Chem"},{"key":"1134_CR31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1524-4741.2008.00572.x","volume":"14","author":"H Wang","year":"2008","unstructured":"Wang H, Arun BK, Fuller GN, Zhang W, Middleton LP, Sahin AA: IGFBP2 and IGFBP5 overexpression correlates with the lymph node metastasis in T1 breast carcinomas. Breast J. 2008, 14: 261-267. 10.1111\/j.1524-4741.2008.00572.x","journal-title":"Breast J"},{"key":"1134_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1677\/jme.1.01955","volume":"37","author":"KW Frommer","year":"2006","unstructured":"Frommer KW, Reichenmiller K, Schutt BS, Hoeflich A, Ranke MB, Dodt G, Elmlinger MW: IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578T. J Mol Endocrinol. 2006, 37: 13-23. 10.1677\/jme.1.01955","journal-title":"J Mol Endocrinol"},{"key":"1134_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0014-5793(98)01011-4","volume":"434","author":"A Hoflich","year":"1998","unstructured":"Hoflich A, Lahm H, Blum W, Kolb H, Wolf E: Insulin-like growth factor-binding protein-2 inhibits proliferation of human embryonic kidney fibroblasts and of IGF-responsive colon carcinoma cell lines. FEBS Lett. 1998, 434: 329-334. 10.1016\/S0014-5793(98)01011-4","journal-title":"FEBS Lett"},{"key":"1134_CR34","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1002\/ijc.25899","volume":"129","author":"K Ueno","year":"2011","unstructured":"Ueno K, Hirata H, Majid S, Tabatabai ZL, Hinoda Y, Dahiya R: IGFBP-4 activates the Wnt\/beta-catenin signaling pathway and induces M-CAM expression in human renal cell carcinoma. Int J Cancer. 2011, 129: 2360-2369. 10.1002\/ijc.25899","journal-title":"Int J Cancer"},{"key":"1134_CR35","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nature03319","volume":"434","author":"T Reya","year":"2005","unstructured":"Reya T, Clevers H: Wnt signalling in stem cells and cancer. Nature. 2005, 434: 843-850. 10.1038\/nature03319","journal-title":"Nature"},{"key":"1134_CR36","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/modpathol.3800562","volume":"19","author":"L Nakopoulou","year":"2006","unstructured":"Nakopoulou L, Mylona E, Papadaki I, Kavantzas N, Giannopoulou I, Markaki S, Keramopoulos A: Study of phospho-beta-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcome. Mod Pathol. 2006, 19: 556-563. 10.1038\/modpathol.3800562","journal-title":"Mod Pathol"},{"key":"1134_CR37","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/jcb.21505","volume":"102","author":"N Gavert","year":"2007","unstructured":"Gavert N, Ben-Ze\u2019ev A: beta-Catenin signaling in biological control and cancer. J Cell Biochem. 2007, 102: 820-828. 10.1002\/jcb.21505","journal-title":"J Cell Biochem"},{"key":"1134_CR38","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1158\/1078-0432.CCR-09-2943","volume":"16","author":"F Takahashi-Yanaga","year":"2010","unstructured":"Takahashi-Yanaga F, Kahn M: Targeting Wnt signaling: can we safely eradicate cancer stem cells?. Clin Cancer Res. 2010, 16: 3153-3162. 10.1158\/1078-0432.CCR-09-2943","journal-title":"Clin Cancer Res"},{"key":"1134_CR39","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1073\/pnas.060025397","volume":"97","author":"SY Lin","year":"2000","unstructured":"Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell RG, Hung MC: Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA. 2000, 97: 4262-4266. 10.1073\/pnas.060025397","journal-title":"Proc Natl Acad Sci USA"},{"key":"1134_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.gde.2005.12.007","volume":"16","author":"FH Brembeck","year":"2006","unstructured":"Brembeck FH, Rosario M, Birchmeier W: Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev. 2006, 16: 51-59. 10.1016\/j.gde.2005.12.007","journal-title":"Curr Opin Genet Dev"},{"key":"1134_CR41","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1038\/emboj.2012.150","volume":"31","author":"T Valenta","year":"2012","unstructured":"Valenta T, Hausmann G, Basler K: The many faces and functions of beta-catenin. EMBO J. 2012, 31: 2714-2736. 10.1038\/emboj.2012.150","journal-title":"EMBO J"},{"key":"1134_CR42","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI119298","volume":"99","author":"PC Brooks","year":"1997","unstructured":"Brooks PC, Klemke RL, Schon S, Lewis JM, Schwartz MA, Cheresh DA: Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo. J Clin Invest. 1997, 99: 1390-1398. 10.1172\/JCI119298","journal-title":"J Clin Invest"},{"key":"1134_CR43","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/sj.onc.1202172","volume":"17","author":"CC Kumar","year":"1998","unstructured":"Kumar CC: Signaling by integrin receptors. Oncogene. 1998, 17: 1365-1373. 10.1038\/sj.onc.1202172","journal-title":"Oncogene"},{"key":"1134_CR44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.bbrc.2009.06.088","volume":"387","author":"S Andersson","year":"2009","unstructured":"Andersson S, D\u2019Arcy P, Larsson O, Sehat B: Focal adhesion kinase (FAK) activates and stabilizes IGF-1 receptor. Biochem Biophys Res Commun. 2009, 387: 36-41. 10.1016\/j.bbrc.2009.06.088","journal-title":"Biochem Biophys Res Commun"},{"key":"1134_CR45","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nature10661","volume":"481","author":"KJ Png","year":"2011","unstructured":"Png KJ, Halberg N, Yoshida M, Tavazoie SF: A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature. 2011, 481: 190-194. 10.1038\/nature10661","journal-title":"Nature"},{"key":"1134_CR46","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/0092-8674(88)90220-6","volume":"55","author":"AS Tsukamoto","year":"1988","unstructured":"Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE: Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell. 1988, 55: 619-625. 10.1016\/0092-8674(88)90220-6","journal-title":"Cell"},{"key":"1134_CR47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/08977194.2011.582839","volume":"29","author":"I Khan","year":"2011","unstructured":"Khan I, Agarwal P, Thangjam GS, Radhesh R, Rao SG, Kondaiah P: Role of TGF-beta and BMP7 in the pathogenesis of oral submucous fibrosis. Growth Factors. 2011, 29: 119-127. 10.3109\/08977194.2011.582839","journal-title":"Growth Factors"},{"key":"1134_CR48","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1093\/bioinformatics\/btm412","volume":"23","author":"ME Ritchie","year":"2007","unstructured":"Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, Holloway A, Smyth GK: A comparison of background correction methods for two-colour microarrays. Bioinformatics. 2007, 23: 2700-2707. 10.1093\/bioinformatics\/btm412","journal-title":"Bioinformatics"},{"key":"1134_CR49","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S1046-2023(03)00155-5","volume":"31","author":"GK Smyth","year":"2003","unstructured":"Smyth GK, Speed T: Normalization of cDNA microarray data. Methods. 2003, 31: 265-273. 10.1016\/S1046-2023(03)00155-5","journal-title":"Methods"},{"key":"1134_CR50","doi-asserted-by":"crossref","first-page":"Article3","DOI":"10.2202\/1544-6115.1027","volume":"3","author":"GK Smyth","year":"2004","unstructured":"Smyth GK: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004, 3: Article3-","journal-title":"Stat Appl Genet Mol Biol"},{"key":"1134_CR51","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2144\/03342mt01","volume":"34","author":"AI Saeed","year":"2003","unstructured":"Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M: TM4: a free, open-source system for microarray data management and analysis. Biotechniques. 2003, 34: 374-378.","journal-title":"Biotechniques"},{"key":"1134_CR52","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.clcc.2011.03.014","volume":"10","author":"JM Hernandez","year":"2011","unstructured":"Hernandez JM, Farma JM, Coppola D, Hakam A, Fulp WJ, Chen DT, Siegel EM, Yeatman TJ, Shibata D: Expression of the antiapoptotic protein survivin in colon cancer. Clin Colorectal Cancer. 2011, 10: 188-193. 10.1016\/j.clcc.2011.03.014","journal-title":"Clin Colorectal Cancer"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-4598-12-63.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:23:55Z","timestamp":1630542235000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/1476-4598-12-63"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,16]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1134"],"URL":"https:\/\/doi.org\/10.1186\/1476-4598-12-63","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,16]]},"assertion":[{"value":"9 October 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"63"}}